Hikma raising injectable opioids output to help ease shortage at U.S. hospitals

London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help ease a shortage of injectable opioids used to treat patients.